Skip to main content

6Node page

what any key link opens

psx:substance/hyoscyamus-niger/value/contraindication/84a1b6a0-f912-421a-ac0d-67e09e7b7462@2

valuereferenced by edges — no row of its own

derived from · upstream

feeds · downstream

none recorded

Closure of psx:substance/hyoscyamus-niger/value/contraindication/84a1b6a0-f912-421a-ac0d-67e09e7b7462@2: 1 upstream, 0 downstream.

psx:substance/hyoscyamus-niger/value/contraindication/84a1b6a0-f912-421a-ac0d-67e09e7b7462@2
└─ derived_from  proposal/contraindication/9144ad78-8b25-4ab1-97eb-07fcaef23d16  contraindication · psychiatric

indented by distance from this node, not by parentage

1Provenance card

the boundary, as counts

Sources

2819 with DOI

3 strong · 22 moderate · 3 weak

Compilations

12026-05-14T06:54:30.081Z

pipeline-v5 · prompt hash not recorded — run predates 2026-09

Decisions

23last ruled 2026-06-04

0 awaiting a ruling

Issued documents

52026-10-19T20:32:18.114Z

notice · info card · emergency

Searches

240 with no results

queries and counts on the build

Claims checked

7838 supported

38 supported · 40 not

Correspondence

0received

consent field ships in Phase 4

Edges

244

derivations recorded for this entity

Complete over 28 sources, 1 compilation, and 23 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/hyoscyamus-niger/archive

2Build

one panel per compilation run

generation run 2026-05-14

82 min completedmodel pipeline-v5plan not recordedrun/ef13f8b0…

Selection

results seen116
selected by the model48
consumed as sources28

Verification

claims checked78
supported37
partially supported1
not supported0
inconclusive40
  • record
  • seen / partial
  • working

The model's own caveats

3 further caveats recorded as free text — readable on the working page

Reproduce

inputs
28 source keys (listed under Sources)
plan
not recorded — template version, prompt hash and git SHA are written from 2026-09 onward
model
pipeline-v5
streams
none — agent transcripts are persisted from 2026-09 onward
24 searches — query, source, results, what was kept and why
24 searches for this run
#sourcequeryseenkeptrationale
1PubChematropine11Atropine is the racemate of hyoscyamine; relevant to pharmacology
2PubMedHyoscyamus niger scopolamine hyoscyamine tropane alkaloids concentration134Ahmadpour provides H. niger-specific alkaloid concentrations; Hashimoto is key for biosynthesis
3PubChemscopolamine11Chemical identity verification for primary alkaloid
4OpenAlexHyoscyamus niger phytochemistry pharmacology153EFSA opinion and Swiss poisoning data are strong sources for safety section
5PubMedhenbane Hyoscyamus niger anticholinergic poisoning delirium hallucination11Key clinical toxicology reference for H. niger specifically
6PubMedscopolamine pharmacokinetics bioavailability half-life human83These provide pharmacokinetic data for the primary alkaloid scopolamine
7PubMedHyoscyamus niger review pharmacology alkaloids42Both highly relevant: Shim covers pharmacology/mechanism; Fatur & Kreft covers intoxication data for H. niger specifically
8PubChemhyoscyamine11Chemical identity verification for primary alkaloid
9PMC - PubMed CentralHyoscyamus niger alkaloid content toxic dose13Key quantitative data source for alkaloid content and dosing
10GoogleHyoscyamus niger history ancient Rome Vikings beer brewing103Historical/ethnobotanical use documentation for history section
11GoogleHyoscyamus niger legal status Europe UK Germany France scheduled controlled101Legal status data not findable via API tools
12USDA Forest ServiceHyoscyamus niger history traditional use13Authoritative USDA ethnobotany source on traditional uses
13ErowidHyoscyamus niger legal status12Primary legal status source for H. niger
14POWO - Plants of the World OnlineHyoscyamus niger taxonomy11Authoritative taxonomy database - provides accepted binomial and distribution
15PubMedscopolamine anticholinergic tolerance dependence withdrawal10No relevant results - gap noted for dependence data
16MultipleAlkaloid content comparison across H. niger plant sources43Synthesizes alkaloid quantification data across multiple H. niger studies
17WebSearchHyoscyamus niger Australia legal status101Australian legal status not clearly determinable from available sources
18DOI verification - CrossrefDOI 10.1016/j.toxicon.2020.02.005 and 10.2903/j.efsa.2013.338622DOI verification for key safety references
19PubMedHenbane chewing PMID 97979811Only documented case report of deliberate H. niger consumption for psychoactive effect
20PubMedscopolamine detection urine hair PMID 3703019911Documents detection windows for scopolamine in biological specimens
21Multiple primary sources cross-referenceSynthesis of H. niger safety, dose, and toxicology data86Core safety and toxicology data synthesis
22PMC/PubMedTeodorico Borgognoni anesthetic preparations medieval henbane PMID 3776331611Historical documentation of H. niger in medieval medical practice
23OpenAlexHyoscyamus niger henbane history traditional medicine ethnobotany103Ethnobotany and historical documentation sources
24WebSearchHyoscyamus niger noxious weed invasive status US states Canada101Legal status distinction between noxious weed and controlled substance
78 claims by section — every cited sentence, checked against its source
safety33 · 17 ok
  • Claim in safety — inconclusiveinconclusiveworking →

  • A retrospective analysis of 815 anticholinergic toxidrome patients found physostigmine associated with a lower intubation rate (1.9% vs 8.4%).supported

    Retrospective analysis of 815 anticholinergic toxidrome patients; physostigmine associated with lower intubation rate (1.9% vs 8.4%). s13181-014-0452-x

  • H. niger is a highly toxic plant; all parts — leaves, seeds, and roots — contain pharmacologically active tropane alkaloids.supported

    Black henbane (BH) or Hyoscyamus niger... Clinical manifestations of acute BH poisoning are very wide which include mydriasis, tachycardia, arrhythmia, agitation, convulsion and coma... pmid:25386392

  • H. niger is a highly toxic plant; all parts — leaves, seeds, and roots — contain pharmacologically active tropane alkaloids.supported

    Poisonous plants from Solanaceae family (Hyoscyamus niger...) are rich sources of tropane alkaloids. s13659-022-00357-w

  • The European Food Safety Authority (EFSA) established a group Acute Reference Dose (ARfD) of 0.016 µg/kg body weight (sum of hyoscyamine and scopolamine, assuming equal potency) based on decreased heart rate in a human volunteer study.supported

    Group ARfD of 0.016 µg/kg body weight established based on decreased heart rate in human volunteer study. j.efsa.2013.3386

  • Claim in safety — inconclusiveinconclusiveworking →

  • At severe doses: arrhythmia, convulsions, and coma.supported

    Clinical manifestations of acute BH poisoning are very wide which include... arrhythmia, agitation, convulsion and coma... pmid:25386392

  • The Swiss Toxicology Information Center documented 3 severe H. niger poisoning cases with anticholinergic syndrome among 152 total severe plant poisoning cases over a 29-year period (1966–1994) — compared with 42 cases for Atropa belladonna and 17 for Datura stramoniumsupported

    H. niger: 3 cases with anticholinergic syndrome among 152 severe plant poisoning cases in 29 years. Also documented: Atropa belladonna 42 cases, Datura stramonium 17 cases. pmid:8711457

  • A European review of anticholinergic Solanaceae intoxications (1966–2018) found that H. niger poisonings primarily result from the plant being mistaken for edible species; intentional use for psychoactive effect was substantially less common than for Daturasupported

    Datura stramonium, Atropa belladonna, Hyoscyamus niger, and Scopolia carniolica... H. niger was found to be largely ingested when mistaken for other plants. j.toxicon.2020.02.005

  • In Australia, a 1976 case report of deliberate henbane flower chewing noted "more widespread use of this plant among the drug-taking community," suggesting unreported cases.supported

    Case of deliberate chewing of henbane (Hyoscyamus niger) flowers to produce euphoria resulting in poisoning. Indicates use among drug-taking community in Australia. pmid:979798

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Elderly: Heightened anticholinergic sensitivity with significantly elevated risk of delirium; long-term anticholinergic exposure is associated with increased dementia risksupported

    Long-term anticholinergic exposure linked to dementia and neurodegenerative disease risk; mechanisms including vascular and neuroinflammatory pathways reviewed. jnc.15244

  • Claim in safety — inconclusiveinconclusiveworking →

  • The primary psychoactive effect of H. niger at doses achievable from plant material is delirium — an agitated, non-lucid state characterized by hallucinations and confusion that is not voluntarily controllablesupported

    Clinical manifestations of acute BH poisoning are very wide which include... auditory, visual or tactile hallucinations, confusion, disorientation, delirium, aggressiveness, and combative behavior. pmid:25386392

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • Claim in safety — inconclusiveinconclusiveworking →

  • The following medication categories carry established anticholinergic properties that are additive with H. niger alkaloids:supported

    Overview of pharmacokinetic and pharmacodynamic herb-drug interactions; CYP enzyme induction/inhibition; additive and antagonistic effects. fphar.2012.00069

  • Claim in safety — inconclusiveinconclusiveworking →

  • A randomized trial found physostigmine superior to lorazepam for treatment of antimuscarinic toxidrome, and a prospective study from a regional poison center confirmed its superiority over non-antidote therapysupported

    Prospective investigation of physostigmine vs non-antidote therapy for antimuscarinic delirium in a regional poison center. 15563650.2018.1485154

  • Claim in safety — inconclusiveinconclusiveworking →

  • Elderly: Age-related increase in anticholinergic sensitivity; long-term exposure associated with dementia risksupported

    Long-term anticholinergic exposure linked to dementia and neurodegenerative disease risk; mechanisms including vascular and neuroinflammatory pathways reviewed. jnc.15244

  • Claim in safety — inconclusiveinconclusiveworking →

  • LC-MS/MS can detect both alkaloids in serum (limit of detection 0.02 ng/mL) and urine (170–670 ng/mL in clinical poisoning cases)supported

    LC/MS/MS method for hyoscyamine and scopolamine in serum/urine. Detection limit 0.02 ng/mL. In Datura poisoning cases: serum 0.45-3.5 ng/mL; urine 170-670 ng/mL. pmid:18787311

  • In a drug-facilitated sexual assault case, scopolamine was detected in urine at 41 µg/L at 18 hours post-exposure, and in hair at 0.37 pg/mg at 5 weeks post-exposure; blood was negative at 18 hourssupported

    Scopolamine detected in urine at 41 µg/L (18h post-exposure) and in hair at 0.37 pg/mg (5 weeks post-exposure) in DFSA case. Blood negative at 18h. j.forsciint.2023.111678

  • Claim in safety — inconclusiveinconclusiveworking →

  • Management: (1) supportive care as the mainstay; (2) activated charcoal if ingestion was recent and airway is protected — not ipecac; (3) benzodiazepines for agitation and seizure prevention; (4) physostigmine for severe anticholinergic delirium; (5) active temperature management for hyperthermia; (6) cardiac monitoring for arrhythmiasupported

    Physostigmine vs lorazepam comparison for antimuscarinic delirium and agitation treatment in clinical trial. 15563650.2020.1854281

  • Management: (1) supportive care as the mainstay; (2) activated charcoal if ingestion was recent and airway is protected — not ipecac; (3) benzodiazepines for agitation and seizure prevention; (4) physostigmine for severe anticholinergic delirium; (5) active temperature management for hyperthermia; (6) cardiac monitoring for arrhythmiasupported

    Prospective investigation of physostigmine vs non-antidote therapy for antimuscarinic delirium in a regional poison center. 15563650.2018.1485154

  • Claim in safety — inconclusiveinconclusiveworking →

alkaloid-profile12 · 7 ok
  • HPLC-DAD analysis of H. niger roots under optimized ultrasound-assisted extraction yielded hyoscyamine at 164.72 µg/g dry weight and scopolamine at 209.23 µg/g dry weight, confirming that scopolamine exceeds hyoscyamine in root tissuesupported

    The optimal extraction yielded hyoscyamine 164.72 µg/g dry weight and scopolamine 209.23 µg/g dry weight from H. niger roots. j.heliyon.2024.e38856

  • Wild-type hairy root cultures produced hyoscyamine at approximately 54 µg/g dry weight as a baseline reference.supported

    Wild-type H. niger hairy roots baseline data: hyoscyamine ~54 µg/g. s41598-018-36156-y

  • Three minor tropane alkaloids have been confirmed in H. niger. Anisodamine has been identified by HPLC. Cuscohygrine occurs primarily in roots, reaching 26.5 mg/g dry weight in hairy root bioreactor cultures. Apoatropine is present in whole-plant preparationssupported

    Scopolamine, hyoscyamine and cuscohygrine concentrations were highest in the bubble-column reactor (5.3, 1.6 and 26.5 mg/g dry wt, respectively). Also detected: anisodamine. s10529-013-1426-9

  • Three minor tropane alkaloids have been confirmed in H. niger. Anisodamine has been identified by HPLC. Cuscohygrine occurs primarily in roots, reaching 26.5 mg/g dry weight in hairy root bioreactor cultures. Apoatropine is present in whole-plant preparationssupported

    Anisodamine and scopolamine are both found in H. niger. HnArAT3 gene involved in phenyllactic acid branch of TA biosynthetic pathway. pmid:29911833

  • Three minor tropane alkaloids have been confirmed in H. niger. Anisodamine has been identified by HPLC. Cuscohygrine occurs primarily in roots, reaching 26.5 mg/g dry weight in hairy root bioreactor cultures. Apoatropine is present in whole-plant preparationssupported

    Scopolamine, hyoscyamine and cuscohygrine concentrations were highest in the bubble-column reactor (5.3, 1.6 and 26.5 mg/g dry wt, respectively). Also detected: anisodamine. s10529-013-1426-9

  • Claim in alkaloid-profile — inconclusiveinconclusiveworking →

  • Claim in alkaloid-profile — inconclusiveinconclusiveworking →

  • Claim in alkaloid-profile — inconclusiveinconclusiveworking →

  • Claim in alkaloid-profile — inconclusiveinconclusiveworking →

  • The terminal step is catalyzed by hyoscyamine 6β-hydroxylase (H6H), a 2-oxoglutarate-dependent dioxygenase first purified and characterized from H. niger root culturessupported

    Hyoscyamine 6 beta-hydroxylase, a 2-oxoglutarate-dependent dioxygenase that catalyzes the hydroxylation of l-hyoscyamine to 6 beta-hydroxyhyoscyamine in the biosynthetic pathway leading to scopolamine. pmid:3569262

  • Claim in alkaloid-profile — inconclusiveinconclusiveworking →

  • The complete biosynthetic pathway from amino acid precursors to scopolamine has been reconstructed in yeast, confirming each enzymatic step.supported

    Complete biosynthesis of hyoscyamine and scopolamine reconstructed in yeast; full pathway from amino acids to final alkaloids established. s41586-020-2650-9

preparations11 · 3 ok
  • For reference, pharmaceutical transdermal scopolamine patches deliver 0.5 mg over 72 hours from a 1.5 mg reservoir.supported

    TTS-patch delivers 0.5 mg over 72h. pmid:16175141

  • Claim in preparations — inconclusiveinconclusiveworking →

  • Claim in preparations — inconclusiveinconclusiveworking →

  • Claim in preparations — inconclusiveinconclusiveworking →

  • Claim in preparations — inconclusiveinconclusiveworking →

  • One documented case of deliberate henbane flower chewing in an adult resulted in acute anticholinergic poisoning.supported

    Case of deliberate chewing of henbane (Hyoscyamus niger) flowers to produce euphoria resulting in poisoning. pmid:979798

  • Claim in preparations — inconclusiveinconclusiveworking →

  • Contamination of commercial herbal teas by H. niger seeds has been documented as a food safety concernsupported

    Routes of intentional and unintentional tropane alkaloid poisoning reviewed. Concentrations highest in roots and seeds. qas2013.0314

  • Claim in preparations — inconclusiveinconclusiveworking →

  • Claim in preparations — inconclusiveinconclusiveworking →

  • Claim in preparations — inconclusiveinconclusiveworking →

neuroscience10 · 4 ok
  • Claim in neuroscience — inconclusiveinconclusiveworking →

  • Hyoscyamine and scopolamine are competitive, non-selective muscarinic acetylcholine receptor (mAChR) antagonists, blocking the neurotransmitter acetylcholine at M1, M2, and M3 receptor subtypes in both the central and peripheral nervous system.supported

    These compounds possess the anticholinergic properties as they could block the neurotransmitter acetylcholine action in the central and peripheral nervous system by binding at either muscarinic and/or nicotinic receptors. s13659-022-00357-w

  • Claim in neuroscience — inconclusiveinconclusiveworking →

  • Claim in neuroscience — inconclusiveinconclusiveworking →

  • Scopolamine (oral): Bioavailability 3–27%, highly variable between individualssupported

    Oral bioavailability 3-27%. pmid:16175141

  • Tmax approximately 0.5 hourssupported

    The maximum drug concentration occurs approximately 0.5 hours after oral administration. pmid:16175141

  • Plasma half-life 4.5 ± 1.7 hourssupported

    After IV, elimination half-life 4.5±1.7 hr. pmid:2762223

  • Claim in neuroscience — inconclusiveinconclusiveworking →

  • Claim in neuroscience — inconclusiveinconclusiveworking →

  • Claim in neuroscience — inconclusiveinconclusiveworking →

summary7 · 3 ok
  • It is classified as a deliriant — its pharmacology is driven by the tropane alkaloids scopolamine and hyoscyamine, which produce anticholinergic toxidrome at doses readily achievable from crude plant materialsupported

    Poisonous plants from Solanaceae family (Hyoscyamus niger...) are rich sources of tropane alkaloids. These compounds possess the anticholinergic properties as they could block the neurotransmitter acetylcholine action in the central and peripheral nervous system. s13659-022-00357-w

  • Claim in summary — inconclusiveinconclusiveworking →

  • Claim in summary — inconclusiveinconclusiveworking →

  • Oral bioavailability of purified scopolamine ranges from 3–27% with a plasma half-life of approximately 4.5 hours; no pharmacokinetic data exist for crude plant preparations.partially supported

    After IV, elimination half-life 4.5±1.7 hr. Oral bioavailability variable, range 10.7-48.2%. pmid:2762223

  • Claim in summary — inconclusiveinconclusiveworking →

  • Claim in summary — inconclusiveinconclusiveworking →

  • Physostigmine, a cholinesterase inhibitor, is the specific antidote for severe anticholinergic toxidromesupported

    Physostigmine vs lorazepam comparison for antimuscarinic delirium and agitation treatment in clinical trial. 15563650.2020.1854281

history3 · 2 ok
  • Teodorico Borgognoni (1205–1296) included narcotic plants — likely including henbane — in his anesthetic preparations documented in Cyrurgia seu filia principissupported

    Medieval anesthetic preparations including narcotic plants; Teodorico Borgognoni (13th century) used henbane-containing preparations as anesthetics. life13091913

  • Contemporary ethnobotanical surveys document continued traditional medicinal use of H. niger in Morocco among High Atlas Tashelhit-speaking communitiessupported

    Ethnomedicinal survey documenting traditional plant use including Hyoscyamus niger in High Atlas Moroccan communities. j.jep.2016.05.009

  • Claim in history — inconclusiveinconclusiveworking →

botanical-overview2 · 2 ok
  • Some cultivation for pharmaceutical alkaloid production has been documented, though commercial-scale tropane alkaloid production has largely shifted to hybrid Duboisia cropssupported

    Commercial-scale alkaloid production from Duboisia hybrid crops; tissue-specific distribution of hyoscyamine, scopolamine and precursors. pcx165

  • Morphological distinctiveness reduces the risk of deliberate product adulteration, but accidental misidentification with edible umbellifers, beets, and garden herbs has been documented in poisoning literaturesupported

    H. niger was found to be largely ingested when mistaken for other plants. j.toxicon.2020.02.005

3Sources

28 consumed · sorted by year · feeds = sections resting on it

Sources
yearsourcetierstatusfeeds
2024Ultrasound-assisted extraction of scopolamine and hyoscyamine from Hyoscyamus niger roots using central compost designAhmadpour R, Zanjani BM, Garoosi GA, Farjaminezhad R, Haddad R · Heliyondoi:10.1016/j.heliyon.2024.e38856moderateconsumed1 section
2023Detection of scopolamine in urine and hair in a drug-facilitated sexual assaultMelchior SE, Nielsen MKK, Oropeza AR, Banner J, Johansen SS · Forensic Science Internationaldoi:10.1016/j.forsciint.2023.111678weakconsumed1 section
2023Teodorico Borgognoni's Formulary for Thirteenth Century Anesthetic PreparationsCavalloro V, Soddu F, Baroni S, et al. · Life (Basel)doi:10.3390/life13091913moderateconsumed1 section
2022Beauty of the beast: anticholinergic tropane alkaloids in therapeuticsShim KH, Kang MJ, Sharma N, An SSA · Natural Products and Bioprospectingdoi:10.1007/s13659-022-00357-wmoderateconsumed4 sections
2021A randomized trial comparing physostigmine vs lorazepam for treatment of antimuscarinic (anticholinergic) toxidromeWang GS, Baker K, Ng P, et al. · Clinical Toxicologydoi:10.1080/15563650.2020.1854281moderateconsumed2 sections
2021Nixing the nightshades: Traditional knowledge of intoxicating members of the Solanaceae among hallucinogenic plant and mushroom users in SloveniaFatur K, Kreft S · PLoS ONEdoi:10.1371/journal.pone.0247688moderateconsumed2 sections
2021Tardive neurotoxicity of anticholinergic drugs: A reviewMarzoughi S, Banerjee A, Jutzeler CR, et al. · Journal of Neurochemistrydoi:10.1111/jnc.15244moderateconsumed1 section
2020Biosynthesis of medicinal tropane alkaloids in yeastSrinivasan P, Smolke CD · Naturedoi:10.1038/s41586-020-2650-9moderateconsumed1 section
2020Common anticholinergic solanaceaous plants of temperate Europe - A review of intoxications from the literature (1966-2018)Fatur K, Kreft S · Toxicondoi:10.1016/j.toxicon.2020.02.005strongconsumed2 sections
2019Physostigmine is superior to non-antidote therapy in the management of antimuscarinic delirium: a prospective study from a regional poison centerBoley SP, Olives TD, Bangh SA, Fahrner S, Cole JB · Clinical Toxicologydoi:10.1080/15563650.2018.1485154moderateconsumed1 section
2018Localization and Organization of Scopolamine Biosynthesis in Duboisia myoporoides R. Br.Kohnen KL, Sezgin S, Spiteller M, Hagels H, Kayser O · Plant and Cell Physiologydoi:10.1093/pcp/pcx165moderateconsumed1 section
2018Targeted expression of Vitreoscilla hemoglobin improves the production of tropane alkaloids in Hyoscyamus niger hairy rootsGuo Z, Tan H, Lv Z, et al. · Scientific Reportsdoi:10.1038/s41598-018-36156-ymoderateconsumed1 section
2017Cloning and characterization of an aromatic amino acid aminotransferase (ArAT) gene involved in tropane alkaloid biosynthesis from Hyoscyamus nigerLi X, Qiang W, Qiu F, et al. · Acta Pharmaceutica Sinicapmid:29911833moderateconsumed1 section
2016An ethnomedicinal survey of a Tashelhit-speaking community in the High Atlas, MoroccoTeixidor-Toneu I, Martin GJ, Ouhammou A, Puri RK, Hawkins JA · Journal of Ethnopharmacologydoi:10.1016/j.jep.2016.05.009moderateconsumed1 section
2015The Use of Physostigmine by Toxicologists in Anticholinergic Toxicity.Watkins JW, Schwarz ES, Arroyo-Plasencia AM, Mullins ME · Journal of Medical Toxicologydoi:10.1007/s13181-014-0452-xmoderateconsumed1 section
2014Black henbane and its toxicity - a descriptive reviewAlizadeh A, Moshiri M, Alizadeh J, Balali-Mood M · Avicenna Journal of Phytomedicinepmid:25386392strongconsumed5 sections
2014Production of tropane alkaloids in Hyoscyamus niger (black henbane) hairy roots grown in bubble-column and spray bioreactorsJaremicz Z, Luczkiewicz M, Kokotkiewicz A, Krolicka A, Sowinski P · Biotechnology Lettersdoi:10.1007/s10529-013-1426-9moderateconsumed1 section
2014Tropane alkaloids in food: poisoning incidentsAdamse P, van Egmond HP, Noordam MY, Mulder P, de Nijs M · Quality Assurance and Safety of Crops & Foodsdoi:10.3920/qas2013.0314weakconsumedcited only
2013Scientific Opinion on Tropane Alkaloids in Food and FeedEFSA Panel on Contaminants in the Food Chain (CONTAM) · EFSA Journaldoi:10.2903/j.efsa.2013.3386moderateconsumed2 sections
2012An Overview of the Evidence and Mechanisms of Herb-Drug InteractionsFasinu PS, Bouic P, Rosenkranz B · Frontiers in Pharmacologydoi:10.3389/fphar.2012.00069moderateconsumed1 section
2008Determination of hyoscyamine and scopolamine in serum and urine of humans by liquid chromatography with tandem mass spectrometryKonishi T, Akaki K, Hatano K · Journal of the Food Hygienic Society of Japanpmid:18787311moderateconsumed1 section
2005Pharmacokinetics and pharmacodynamics in clinical use of scopolamineRenner UD, Oertel R, Kirch W · Therapeutic Drug Monitoringpmid:16175141moderateconsumed5 sections
2001Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effects of scopolamine in healthy volunteersEbert U, Grossmann M, Oertel R, Gramatte T, Kirch W · Journal of Clinical Pharmacologypmid:11144994moderateconsumed1 section
1999Medicinal Plants and Alzheimer's Disease: from Ethnobotany to PhytotherapyPerry EK, Pickering AT, Wang WW, Houghton PJ, Perry NS · Journal of Pharmacy and Pharmacologydoi:10.1211/0022357991772808moderateconsumedcited only
1996Serious plant poisonings in Switzerland 1966-1994. Case analysis from the Swiss Toxicology Information CenterJaspersen-Schib R, Theus L, Guirguis-Oeschger M, Gossweiler B, Meier-Abt PJ · Schweizerische Medizinische Wochenschriftpmid:8711457moderateconsumed1 section
1989Pharmacokinetics and oral bioavailability of scopolamine in normal subjectsPutcha L, Cintrón NM, Tsui J, Vanderploeg JM, Kramer WG · Pharmaceutical Researchpmid:2762223strongconsumed2 sections
1987Purification and characterization of hyoscyamine 6 beta-hydroxylase from root cultures of Hyoscyamus niger L.Hashimoto T, Yamada Y · European Journal of Biochemistrypmid:3569262moderateconsumed1 section
1976Henbane chewingSands JM, Sands R · Medical Journal of Australiapmid:979798weakconsumed2 sections

4Docket

one filing per activity — decisions, correspondence, reports

  1. 0012026-03-17importImported from Curiosity v1

    imported 2026-03; original sourcing not recoverable

    psx:substance/hyoscyamus-niger/import/curiosity-v1
  2. 0022026-03-17publicationPublication — backfill
  3. 0032026-03-17revisionRevision 1
  4. 0042026-05-14revisionRevision 2

    Initial LLM generation (plant pipeline v1, wiki, prose phase)

    psx:substance/hyoscyamus-niger/version/2
  5. 0052026-06-04proposal18 value proposals approved together

    one review action inferred from a shared reviewer and instant — the graph records one activity per proposal

    18 items in this filing

    • contraindication · pregnancy_breastfeeding
    • contraindication · age
    • contraindication · cardiovascular
    • contraindication · renal
    • contraindication · other
    • contraindication · hepatic
    • contraindication · psychiatric
    • contraindication · age
    • dose_tier · threshold
    • dose_tier · light
    • dose_tier · common
    • dose_tier · strong
    • dose_tier · heavy
    • toxicity
    • dependence · full
    • withdrawal
    • tolerance
    psx:substance/hyoscyamus-niger/proposal/contraindication/0ae6b0ed-6c93-4672-8a5a-c24a833f9a33
  6. 0062026-06-04publicationPublication — backfill

5Issued documents

what the notice, info card and emergency page said, by hash

Issued documents
documentcontent hashissuedfrom versionsuperseded
emergency202c57e4fe575e44059df0ab…2026-10-19 20:32Revision 2current
info_carddc0cc18f30b207b33d7785d4…2026-10-19 20:32Revision 2current
emergencye2acd002694f8aad19cda75f…2026-09-04 04:30Revision 2superseded2026-10-19
info_card1fb004e05d184ec8363725b7…2026-09-04 04:30Revision 2superseded2026-10-19
noticef56c8fd9c2e621c56e23833a…2026-09-04 04:30Revision 2current